aUniversity of Washington, Seattle, WA;
bUniversity of California, Los Angeles, CA;
cWake Forest University, Winston-Salem, NC;
dRush University, Chicago, IL;
eNorthwestern University, Evanston, IL;
fJohns Hopkins University, Baltimore, MD;
gUniversity of California, San Diego, CA;
hUniversity of California, San Francisco, CA;
iUniversity of Alabama Birmingham, Birmingham, AL;
jUniversity of North Carolina, Chapel Hill, NC; and
kUniversity of Manitoba, Winnipeg, Manitoba, Canada.
Correspondence to: Heidi M. Crane, MD, MPH, University of Washington, Harborview Medical Center, 325 9th Avenue, Box 359931, Seattle, WA 98104 (e-mail: [email protected]).
Supported by the National Institute on Aging at the National Institutes of Health Grants R24 AG044325 and R33AG067069. Additional support came from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (CNICS R24 AI067039, UW CFAR NIAID Grant P30 AI027757, and UAB CFAR Grant P30 AI027767). Additional support came from the National Heart, Lung, and Blood Institute at the National Institutes of Health R01 HL126538.
Presented in part at the Conference on Retroviruses and Opportunistic Infections; March 6, 2019; Seattle, WA.
H.M.C. has received grant funding from ViiV and was on an advisory board for Theratech. The remaining authors have no conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).
